about
Novel Immunodominant Peptide Presentation Strategy: a Featured HLA-A*2402-Restricted Cytotoxic T-Lymphocyte Epitope Stabilized by Intrachain Hydrogen Bonds from Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid ProteinA decade after SARS: strategies for controlling emerging coronavirusesCD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza virusesUsing 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.Coronaviruses post-SARS: update on replication and pathogenesis.Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope predictionT cell epitope specificity and pathogenesis of mouse hepatitis virus-1-induced disease in susceptible and resistant hosts.Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitopeHuman CD8⁺ and CD4⁺ T cell memory to lymphocytic choriomeningitis virus infection.A review of genetic methods and models for analysis of coronavirus-induced severe pneumonitis.Understanding the T cell immune response in SARS coronavirus infectionRevival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development.NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients.Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC.Retroviral Pseudotypes
P2860
Q27664523-98325384-427B-42C8-A087-40D62E302E7AQ28817689-59C031D6-E07D-46E5-AF92-D77CB2110BF9Q30398319-9889D367-1A8E-4F62-83BE-1ADA4B178B9FQ33609436-D2A98727-2FCD-498E-9616-A3B4A0A87D1CQ33614444-9DADA296-1570-412D-B766-E56726EB9BC6Q33694361-3C29DF16-8115-4A13-8857-BB49336384F3Q33900413-2AA610D3-596C-4A13-8347-A1095D85105BQ33965405-9B770B8E-1608-4E3C-A39C-4639A855C360Q35274855-7A2A0294-C29E-4B37-981D-A552B2349E63Q35531223-108880A6-49B0-4574-9B6D-E01D9119442CQ36739375-11DFEF14-2830-4FE0-B91C-8FF6A5E88AADQ36795319-7C6E1B6E-4DE9-428C-BAEF-04A2AE6D6EBEQ37844333-33C48C6F-96CC-4339-B113-16ABAF6E2CFBQ39150340-C2EBD8DC-676E-4A36-8009-EE1517931210Q39882299-84A8B6F5-2620-4483-8FB6-8EC45BCE22E8Q40428932-706BAF96-F162-49CD-99B6-60818247E602Q58382475-10145468-C000-46A0-94D0-B97DF69AAE76
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
T cell responses to whole SARS coronavirus in humans.
@en
T cell responses to whole SARS coronavirus in humans.
@nl
type
label
T cell responses to whole SARS coronavirus in humans.
@en
T cell responses to whole SARS coronavirus in humans.
@nl
prefLabel
T cell responses to whole SARS coronavirus in humans.
@en
T cell responses to whole SARS coronavirus in humans.
@nl
P2093
P2860
P50
P1476
T cell responses to whole SARS coronavirus in humans.
@en
P2093
Andrew J McMichael
Bac-Hai Tran
Chen-lung Steve Lin
Chris Ka-fai Li
Daniel C Douek
Huiping Yan
Jason M Brenchley
Jin-lin Hou
P2860
P304
P356
10.4049/JIMMUNOL.181.8.5490
P407
P577
2008-10-01T00:00:00Z